Biomaterials Companies and Market Analysis
The biomaterials market contains all sorts of biomaterials such as ceramics, composites, biodegradable, orthopaedic materials, etc. The market is predicted to attain $130.57 billion via 2020, at a development of CGAR of 16% from 2015-2020 prediction. Biomaterials have functions in the discipline of oncology i.e, the learn about of prevention, remedy of cancer. Few biomaterials organizations that are comprised in the international biomaterials market are Zimmer Biomet Holdings, Inc. (U.S.), Carpenter Technology Corporation (U.S.), Covalon Technologies Ltd. (Canada), Evonik Industries AG (Germany), BASF SE (Germany), Invibio Ltd. (U.K.), Berkeley Advanced Biomaterials, Inc. (U.S.), CAM Bioceramics BV (Netherlands), and Collagen Matrix, Inc. (U.S.)
Related Conference of Biomaterials Companies and Market Analysis
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Biomaterials Companies and Market Analysis Conference Speakers
Recommended Sessions
- 3D Printing of Biomaterials
- Advanced Biomaterials
- Bio-based Materials and Sustainability
- Bio-Nanomaterials
- Biodegradable Biomaterials
- Biofunctional Materials
- Bioinspired Materials
- Bioinspired Materials
- Biomaterials
- Biomaterials and Nanotechnology
- Biomaterials and Nanotechnology
- Biomaterials Applications
- Biomaterials Applications
- Biomaterials Companies and Market Analysis
- Biomaterials in Drug Delivery Systems
- Biophotonics and Biomedical Optics
- Dental Biomaterials
- Polymer Biomaterials
- Properties of Biomaterials
- Tissue Engineering and Regenerative Medicine
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)

